Pascal Soriot, AstraZeneca CEO (David Zorrakino/Europa Press via AP)

February 9, 2023 03:39 PM ESTUpdated 04:49 PM

AstraZeneca CEO Pascal Soriot aims for 15 new drug launches by 2030

Nicole DeFeudis

Editor

AstraZeneca CEO Pascal Soriot on Thursday unveiled ambitious plans to launch 15 new drugs by 2030 — and he’s wasting no time, with 30 Phase III …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

TRENDING NOW

'Go ahead and do it': Top RFK Jr. deputy dares drugmakers that might pull manufacturing over new price pressure

The inside story of the six-month sprint to create the first custom CRISPR therapy for one infant’s rare disease

New CBER chief Prasad is readying 'massive framework' around vaccines, Makary says

Eli Lilly turns to South Korean RNA editing biotech for hearing loss in deal worth $1.3B

Bristol Myers CEO says America’s biopharma pole position is not guaranteed

Exclusive: Drug compounder Empower was built on risky shortcuts, ex-employees and inspections allege